to avoid the inhibitory effect of ehdp on bone mineralization , a variety of diphosphonates ( cl2mdp , apd ) and a combination of ehdp with calcitonin have been used in the treatment of paget 's disease .
C0012544
diphosphonates
C0012081
cl2mdp